Founded in 2017, KENOTECH LLC is dedicated to engineering technologies for critical Health and Defense needs of the US. We are currently focused on assistive, diagnostic, and therapeutic technologies that can alleviate the burdens of Alzheimers Disease, a degenerative brain condition characterized by a dynamic combination of cognitive and psychiatric symptoms including loss of memories (i.e., amnesia), language abilities (i.e., aphasia), motor functions (i.e., apraxia), and senses (i.e., agnosia), in addition to personality changes, anxiety, depression, hallucinations, and delusions. We are also developing nanotechnologies for additive and hybrid materials manufacturing for Defense applications.